About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in San Diego | 12,589 Studies Near You | Clareo Health

Clinical Trials LocationsSan Diego

Clinical Trials in San Diego

Discover 12,589 clinical trials near San Diego, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 12061-12080 of 12,589 trials

COMPLETEDPhase 1< 1 mile

Infliximab (Remicade) for Patients With Acute Kawasaki Disease

NCT00271570

This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.

Kawasaki Disease

University of California, San Diego24 participantsStarted Apr 2004

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

NCT00350636

A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.

Overactive Bladder

Watson Pharmaceuticals789 participantsStarted Jun 2006

Birmingham, Alabama, United States • Homewood, Alabama, United States • Mobile, Alabama, United States +60 more locations

Find Trials by Condition in San Diego

Breast Cancerin San Diego Lung Cancerin San Diego Prostate Cancerin San Diego Colorectal Cancerin San Diego Melanomain San Diego Leukemiain San Diego Lymphomain San Diego Pancreatic Cancerin San Diego Ovarian Cancerin San Diego Brain Cancerin San Diego

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

NCT00259012

The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.

Gastroesophageal Reflux

Wyeth is now a wholly owned subsidiary of Pfizer67 participantsStarted Nov 2005

Little Rock, Arkansas, United States • Loma Linda, California, United States • San Diego, California, United States +28 more locations

COMPLETEDPhase 3< 1 mile

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

NCT00868296

The purpose of this study is to provide additional information on safety and tolerability after multiple does of pantoprazole. Only patients who successfully completed the 3001B3-331 study (NCT00362609) or 3001B3-333 study (NCT00259012) are eligible to participate in this study.

Gastroesophageal Reflux

Wyeth is now a wholly owned subsidiary of Pfizer58 participantsStarted Mar 2006

Phoenix, Arizona, United States • Loma Linda, California, United States • Oakland, California, United States +68 more locations

TERMINATEDPhase 2< 1 mile

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT00143247

This is a long-term safety study for Phase 2 subjects who choose to remain on Exubera® (inhaled insulin).

Diabetes Mellitus

Pfizer173 participantsStarted Mar 2003

San Diego, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

NCT00641329

The purpose of this study is to determine if CLONICEL (clonidine HCl sustained release) is a safe and effective add-on to psychostimulant therapy in children and adolescents with attention deficit hyperactivity disorder (ADHD).

Addrenex Pharmaceuticals, Inc.198 participantsStarted Feb 2008

Little Rock, Arkansas, United States • El Centro, California, United States • Irvine, California, United States +20 more locations

COMPLETEDPhase 334 miles

E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

NCT00236184

The purpose of this study is to investigate the safety and efficacy of rabeprazole sodium 10 mg in treating frequent heartburn.

Eisai Inc.629 participantsStarted Oct 2005

Vista, California, United States

COMPLETEDPhase 469 miles

A Trial of Skin Care Protocols for Facial Resurfacing

NCT01113606

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Facial Photo DamagePeriocular Fine WrinklesPerioral Fine Wrinkles

The Plastic Surgery Foundation

Oxnard, California, United States • Rancho Santa Margarita, California, United States • Greeley, Colorado, United States +6 more locations

COMPLETEDPhase 376 miles

Escitalopram in Adult Patients With Major Depressive Disorder

NCT00668525

This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression. Patients completing the study may be eligible to enter a long-term open-label extension study with escitalopram.

Major Depressive Disorder

Forest Laboratories877 participantsStarted Apr 2008

Phoenix, Arizona, United States • Arcadia, California, United States • Encino, California, United States +42 more locations

COMPLETEDPhase 477 miles

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

NCT00244712

This study was designed to test the safety and effectiveness of EPZICOM(abacavir/lamivudine) and TRUVADA (emtricitabine/tenofovir) for the treatment of HIV infection when both are used in combination with KALETRA (lopinavir/ritonavir) over 96 weeks

GlaxoSmithKline688 participantsStarted Jul 2005

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +71 more locations

COMPLETEDPhase 483 miles

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

NCT00572559

Ventilator-associated pneumonia (VAP) is a commonplace complication of intensive care patients ventilated for longer than 48 hours. Methicillin-resistant Staphylococcus aureus (MRSA) is the cause of late onset VAP in up to about 30% of cases in US hospitals. Ineffective treatment of MRSA VAP clearly leads to prolonged mechanical ventilation and is probably associated with higher mortality. The purpose of this protocol is to directly compare linezolid and vancomycin specifically for MRSA VAP.

Pneumonia, Ventilator-Associated

Pfizer149 participantsStarted Nov 2002

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Palm Springs, California, United States +34 more locations

COMPLETEDPhase 384 miles

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

NCT00365300

To assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD).

Gastroesophageal Reflux

Wyeth is now a wholly owned subsidiary of Pfizer129 participantsStarted Sep 2006

Mobile, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +35 more locations

COMPLETEDPhase 189 miles

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

NCT00703469

This study examines the safety, tolerability, and immunogenicity of a single dose of MDX-1106 in patients with active hepatitis C genotype 1 or mixed hepatitis C genotype infection.

Bristol-Myers Squibb54 participantsStarted Oct 2008

Anaheim, California, United States • San Francisco, California, United States • Springfield, Illinois, United States +4 more locations

COMPLETEDPhase 3109 miles

Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

NCT00016068

RATIONALE: Antivirals such as valganciclovir act against viruses and may be effective in preventing cytomegalovirus. It is not yet known if valganciclovir is effective in preventing cytomegalovirus. PURPOSE: This randomized phase III trial is studying valganciclovir to see how well it works in preventing cytomegalovirus in patients who have undergone donor stem cell transplantation.

Fred Hutchinson Cancer Center184 participantsStarted Jan 2001

Duarte, California, United States • Gainesville, Florida, United States • Detroit, Michigan, United States +4 more locations

COMPLETEDPhase 2111 miles

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT00113516

The purpose of this study is to find out if SU011248 (sunitinib) provides additional benefit when it is given after treatment with two chemotherapy drugs carboplatin and paclitaxel and also if sunitinib is safe for patients with locally advanced and metastatic Non Small Cell Lung Cancer (NSCLC).

Non-small Cell Lung Cancer

Pfizer84 participantsStarted Sep 2005

Los Angeles, California, United States • Newark, Delaware, United States • Newark, Delaware, United States +28 more locations

COMPLETEDPhase 1111 miles

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

NCT00295282

This is a Phase I dose-escalation study of MDX-1100. patients with ulcerative colitis will be enrolled into one of four dose cohorts, to receive of MDX-1100 at 0.3, 1.0, 3.0 or 10mg/kg. Three to six patients will be enrolled at each dose level, starting at the lowest dose level, for a maximum of 24 patients to be enrolled into the study. The study is designed to establish the safety and tolerability of single doses of MDX-1100 administered in dose-escalating cohorts to patients with ulcerative colitis. Other study objectives include characterizing a pharmacokinetic profile and pharmacodynamic effects of MDX-1100 and determination of immunogenic response to MDX-1100.

Ulcerative Colitis

Bristol-Myers Squibb24 participantsStarted Jan 2006

Los Angeles, California, United States • Largo, Florida, United States • Chevy Chase, Maryland, United States +2 more locations

TERMINATEDPhase 2118 miles

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

NCT00509548

Wet age-related macular degeneration (AMD) is caused by the formation and growth of abnormal blood vessels (angiogenesis) in the retina. The new blood vessels have fragile walls and can leak fluid into the retina. The build-up of fluid (edema) under the macula can distort vision or cause vision loss. TG100801 is a topical (eye drop) therapy that has been shown to inhibit ocular angiogenesis, vascular leak, and inflammation in laboratory studies. The primary purpose of this pilot study is to evaluate the ability of topical administration of TG100801 to reduce the amount of fluid in the retina in patients with AMD following 30 days of treatment. An additional objective is to evaluate the safety of TG100801 in patients with AMD.

Macular DegenerationChoroidal Neovascularization

TargeGen7 participantsStarted Jul 2007

Tucson, Arizona, United States • Beverly Hills, California, United States • Winter Haven, Florida, United States +5 more locations

COMPLETEDPhase 1/2431 miles

The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot

NCT00116194

The purpose of this study is to gather preliminary data that will determine the feasibility of conducting a Phase III, randomized, controlled trial (RCT) that will provide definite evidence in the use of physical exercise to prevent mobility disability in older persons.

Physically ChallengedAging

National Institute on Aging (NIA)424 participantsStarted Apr 2004

Palo Alto, California, United States • Winston-Salem, North Carolina, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3458 miles

Herpetic Eye Disease Study (HEDS) II

NCT00000139

To determine whether early treatment (with oral acyclovir) of herpes simplex virus (HSV) ulcerations of the corneal epithelium prevents progression to the blinding complications of stromal keratitis and iridocyclitis. To determine the efficacy of low-dose oral acyclovir in preventing recurrent HSV eye infection in patients with previous episodes of herpetic eye disease. To determine the role of external factors (such as ultraviolet light or corneal trauma) and behavioral factors (such as life stress) on the induction of ocular recurrences of HSV eye infections and disease.

Keratitis, HerpeticOcular Herpes SimplexHerpes Simplex

National Eye Institute (NEI)Started Oct 1992

San Francisco, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 11183 miles

Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.

NCT00860210

This pilot feasibility study is assessing the safety and technical performance of the Neurostep™ System for the restoration of independent gait in subjects with gait disorder (i.e. foot drop) secondary to a CNS lesion (e.g. stroke).

StrokeCraniocerebral Trauma

Neurostream Technologies G.P.14 participantsStarted Oct 2007

Vancouver, British Columbia, Canada • Québec, Quebec, Canada • New Delhi, New Delhi, India +1 more locations

PreviousPage 604 of 630Next

Diabetes

in San Diego

Heart Diseasein San Diego